MedPath

Ceftriaxone Sodium

Ceftriaxone for Injection, USP

Approved
Approval ID

365fc265-8e6c-432f-9fda-911f5f7fb451

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 15, 2022

Manufacturers
FDA

Hospira, Inc

DUNS: 141588017

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ceftriaxone Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0409-7334
Application NumberANDA065168
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ceftriaxone Sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 12, 2017
FDA Product Classification

INGREDIENTS (1)

CEFTRIAXONE SODIUMActive
Quantity: 10 g in 100 mL
Code: 023Z5BR09K
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ceftriaxone Sodium - FDA Drug Approval Details